A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck KGaA plans to double R&D productivity, introduce one new product or major indication every 1.5 years on average; over 50% of new launches to result from external co-development partnerships and strategic in-licensing of assets
Published: November 22, 2022 by Business Wire
AstraZeneca and MSD's Lynparza combined with abiraterone and prednisone or prednisolone has been recommended in the EU for approval as a treatment for metastatic castration-resistant prostate cancer
Published: November 14, 2022 by AstraZeneca AB
Merck KGaA reports Q3 net profit up 21.2% to €926.0M as sales rise 16.8% to €5.8B; life science business records double-digit growth, new products and established healthcare medicines portfolio have strong performance
Published: November 13, 2022 by SeeNews Pharmaceuticals
AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Sanofi, Samsung Biologics partner to reduce emissions in the pharmaceutical supply chain; group operating through the UN’s Sustainable Markets Initiative Health systems task force
Published: November 07, 2022 by FiercePharma
Gerresheimer, Merck develop digital twin for primary packaging to further ensure traceability along the pharmaceutical supply chain; the proof of concept uses blockchain, authentication technologies to anchor physical objects securely in the digital world
Published: October 27, 2022 by PR Newswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count